🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Integra LifeSciences Holdings Corporation

IART Healthcare
$11.91 $-0.42 (-3.41%)
Market Cap: $926.61 M
Gurus Holding
2
Popularity Rank
#3332
% of Shares Held
0.35%
Net Activity (Q2 2026)
+$1.71 M

Guru Ownership Trend

Guru Analysis for Integra LifeSciences Holdings Corporation (IART)

Integra LifeSciences Holdings Corporation (IART), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.2 M.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $1.71 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$2.39 M
Total Buy Value
New Buys 1
Additions 1
-$679,257
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Integra LifeSciences Holdings Corporation (IART)

Major holders include Cliff Asness ($4.64 M), Renaissance Technologies (RenTech) ($188,580). According to the latest reported data, 2 tracked investment managers collectively hold approximately 268,659 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.71 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited IART. The total reported sell value was $679,257.

Yes, 1 managers opened new positions in IART, and 1 increased their existing holdings. The total reported buy value was $2.39 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 90.4% 258,159 $4.64 M Q2 2026
0.00% New Buy 10,500 $188,580 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form